잠시만 기다려 주세요. 로딩중입니다.

Clinical management of abnormal Pap tests: differences between US and Korean guidelines

Journal of Pathology and Translational Medicine 2020년 54권 3호 p.213 ~ 219
원세연, 김미경, 성석주,
소속 상세정보
원세연 ( Won Se-Yeon ) - CHA Gangnam Medical Center Department of Obstetrics and Gynecology
김미경 ( Kim Mi-Kyoung ) - CHA Gangnam Medical Center Department of Obstetrics and Gynecology
성석주 ( Seong Seok-Ju ) - CHA Gangnam Medical Center Department of Obstetrics and Gynecology

Abstract


Cervical cancer has been the most common gynecological cancer in Korea but has become a preventable disease with regular screening and proper vaccination. If regular screening is provided, cervical cancer does not progress to more than carcinoma in situ, due to its comparatively long precancerous duration (years to decades). In 2012, the American Society for Colposcopy and Cervical Pathology published guidelines to aid clinicians in managing women with abnormal Papanicolaou (Pap) tests, and they soon became the standard in the United States. Not long thereafter, the Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology published practical guidelines to reflect the specific situation in Korea. The detailed screening guidelines and management options in the case of abnormal Pap test results are sometimes the same and sometimes different in the United States and Korean guidelines. In this article, we summarize the differences between the United States and Korean guidelines in order to facilitate physicians’ proper management of abnormal Pap test results.

키워드

Cervix uteri; Uterine cervical neoplasms; Screening; Papanicolaou test

원문 및 링크아웃 정보

 

등재저널 정보